Apogee Therapeuticsの空売り状況は、投資家がApogee Therapeuticsの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Apogee Therapeutics (NASDAQ:APGE) 株価情報, 空売り情報

APOGEE THERAPEUTICS INC

Apogee Therapeutics

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Apogee Therapeutics Inc

Piper Sandler analyst Mark Lear maintains Black Stone Minerals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSM#NYSE">BSM</a>) with a Neutral and lowers the price target from $15 to $14.

News

Price Target

Analyst Ratings

Piper Sandler Maintains Neutral on Black Stone Minerals, Lowers Price Target to $14

<a href="https://www.youtube.com/watch?v=wj1QOz3iuCE">https://www.youtube.com/watch?v=wj1QOz3iuCE</a>

General

President Trump Says Want To Offer Iran A New And Better Path Toward A More Hopeful Future; Says Stand Ready To Help Lebanon Create A Future Of Economic Development And Peace With Neighbors; Says We Must All Hope New Syria Government Will Succeed In Stabilizing Country

Piper Sandler analyst Mark Lear maintains APA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APA#NASDAQ">APA</a>) with a Neutral and lowers the price target from $22 to $19.

Piper Sandler Maintains Neutral on APA, Lowers Price Target to $19

UBS analyst Andrew Jones maintains GrafTech International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EAF#NYSE">EAF</a>) with a Neutral and lowers the price target from $1.5 to $0.8.

UBS Maintains Neutral on GrafTech International, Lowers Price Target to $0.8

UBS analyst Jay Sole maintains Urban Outfitters (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URBN#NASDAQ">URBN</a>) with a Neutral and raises the price target from $45 to $54.

URBN

UBS Maintains Neutral on Urban Outfitters, Raises Price Target to $54

Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) rose 10.6% to $659.44 since Monday&#8217;s session open, lifted by a broader rally in tech stocks following a tariff rollback <a href="https://www.benzinga.com/government/regulations/25/05/45347089/wall-street-rips-higher-as-tariff-truce-halts-us-china-economic-escalation">agreement</a> between the US and China.
What To Know: The deal, which slashes US tariffs on Chinese goods from 145% to 30% and Chinese tariffs on US. goods from 125% to 10%, has boosted investor sentiment by easing inflation concerns and improving trade visibility.
The truce, <a href="https://www.benzinga.com/government/regulations/25/05/45347089/wall-street-rips-higher-as-tariff-truce-halts-us-china-economic-escalation">effective May 14</a>, stems from high-level negotiations and signals a de-escalation in the trade war that had weighed on global growth.
Meta is particularly well-positioned to benefit from improved US-China relations. Despite being banned in mainland China, Meta generates significant advertising revenue from Chinese companies seeking to reach overseas consumers on platforms like Facebook and Instagram.
These advertisers, ranging from e-commerce giants to app developers, have been major contributors to Meta's ad business. Eased trade tensions may unlock stronger cross-border ad budgets, further bolstering Meta&#8217;s international revenue streams.
The tariff pause also coincides with <a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45374267/inflation-eases-in-april-as-trumps-tariffs-dont-push-prices-higher">softer-than-expected</a> April CPI data, reducing recession fears and supporting the Fed's cautious stance on rate cuts.
Read Also: <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45374327/bitcoin-ethereum-xrp-dogecoin-wobble-but-traders-see-a-shopping-opportunity">Bitcoin, Ethereum, XRP, Dogecoin Wobble, But Traders See A &#8216;Shopping&#8217; Opportunity</a>
<h2 class="wp-block-heading">How To Buy META Stock</h2>
By now you're likely curious about how to participate in the market for Meta Platforms &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, META has a 52-week high of $740.91 and a 52-week low of $442.65.

Meta Platforms Stock Surges As US-China Tariff Rollback Boosts Tech Sector And Advertising Outlook

Piper Sandler analyst Stephen Scouten initiates coverage on First Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FBNC#NASDAQ">FBNC</a>) with a Neutral rating and announces Price Target of $48.

Initiation

FBNC

Piper Sandler Initiates Coverage On First Bancorp with Neutral Rating, Announces Price Target of $48

Bank of America Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) shares are trading higher Tuesday after the firm disclosed plans to open over 150 new locations across 60 <a href="https://www.benzinga.com/pressreleases/25/05/n45377599/bofa-to-open-150-financial-centers-by-2027-investing-over-5-billion-in-its-network-since-2016" target="_blank" rel="noreferrer noopener">markets by the end of 2027</a>.
The bank expects 40 locations to open this year and another 70 in 2026. Four financial centers are slated for Boise, Idaho, with the first location scheduled to open in nearby Nampa on June 9, 2025.
Recently, the company inaugurated a new flagship financial center at 2 Bryant Park in New York City, which is designed to facilitate connections between clients and financial specialists, among others.
Also Read: <a href="https://www.benzinga.com/25/04/44849372/bank-of-america-analysts-cut-price-target-amid-macro-uncertainty-but-maintain-positive-outlook" target="_blank" rel="noreferrer noopener">Bank Of America Analysts Cut Price Target Amid Macro Uncertainty, But Maintain Positive Outlook</a>
Since 2016, the Charlotte, North Carolina-based bank has invested more than $5 billion in its financial center network through new openings and renovations of existing locations.
In April, Bank of America disclosed that it is ramping up its&nbsp;investment in artificial intelligence, planning to spend $4 billion on AI initiatives over the next year, nearly a third of<a target="_blank" href="https://www.benzinga.com/tech/25/04/44878856/bank-of-america-bets-big-on-ai-with-4-billion-investment-and-its-already-paying-off" rel="noreferrer noopener"> its annual $13 billion tech budget</a>.
Also, in the same month, it reported first-quarter fiscal 2025 net income of $7.4 billion (versus $6.7 billion a year ago) and EPS of $0.90, beating the analyst consensus estimate of $0.81.
Investors can gain exposure to the stock via Invesco KBW Bank ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KBWB#NASDAQ">KBWB</a>) and First Trust Nasdaq Bank ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTXO#NASDAQ">FTXO</a>).
Price Action: Bank of America shares are up 1.74% at $44.12 at the last check on Tuesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45369770/whos-going-to-buy-2-trillion-worth-of-paper-macro-expert-calls-wall-street-rally-a-headline-sugar-rush-as-treasury-yield-spike-signals-bigger-trouble" target="_blank" rel="noreferrer noopener">&#8216;Who&#8217;s Going To Buy $2 Trillion Worth Of Paper?&#8217; Macro Expert Calls Wall Street Rally A &#8216;Headline Sugar Rush&#8217; As Treasury Yield Spike Signals Bigger Trouble</a></li>
</ul>
Image: Shutterstock

Equities

Large Cap

Movers

FTXO

KBWB

Bank Of America Bets On Brick-And-Mortar, Expansion Plans Include 60 Markets Worldwide

Oppenheimer analyst Mitchel Penn maintains Main Street Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAIN#NYSE">MAIN</a>) with a Perform and lowers the price target from $58 to $53.

MAIN

Oppenheimer Maintains Perform on Main Street Capital, Lowers Price Target to $53

WIIM

RGNX

RGNX stock has given up its prior gain. Regenxbio shares were trading higher following Q1 financial results and after the company announced FDA acceptance and priority review of BLA for RGX-121.

Arista Networks (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANET#NYSE">ANET</a>) has outperformed the market over the past 10 years by 25.9% on an annualized basis producing an average annual return of 36.57%. Currently, Arista Networks has a market capitalization of $119.71 billion. 
Buying $100 In ANET: If an investor had bought $100 of ANET stock 10 years ago, it would be worth $2,251.76 today based on a price of $95.32 for ANET at the time of writing.
<h3>Arista Networks's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747150215_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

ANET

$100 Invested In Arista Networks 10 Years Ago Would Be Worth This Much Today

Guggenheim analyst Jonathan Lee maintains Endava (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAVA#NYSE">DAVA</a>) with a Buy and lowers the price target from $40 to $28.

DAVA

Guggenheim Maintains Buy on Endava, Lowers Price Target to $28

Mizuho analyst William Janela maintains Sitio Royalties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STR#NYSE">STR</a>) with a Neutral and lowers the price target from $23 to $22.

Mizuho Maintains Neutral on Sitio Royalties, Lowers Price Target to $22

Guggenheim analyst Shahriar Pourreza maintains NRG Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRG#NYSE">NRG</a>) with a Buy and raises the price target from $138 to $173.

Guggenheim Maintains Buy on NRG Energy, Raises Price Target to $173

Mizuho analyst William Janela maintains Viper Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VNOM#NASDAQ">VNOM</a>) with a Outperform and lowers the price target from $56 to $54.

VNOM

Mizuho Maintains Outperform on Viper Energy, Lowers Price Target to $54

Mizuho analyst Nitin Kumar maintains Range Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RRC#NYSE">RRC</a>) with a Outperform and raises the price target from $45 to $46.

Mizuho Maintains Outperform on Range Resources, Raises Price Target to $46

Guggenheim analyst Curry Baker maintains Tegna (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGNA#NYSE">TGNA</a>) with a Buy and raises the price target from $20 to $22.

TGNA

Guggenheim Maintains Buy on Tegna, Raises Price Target to $22

Mizuho analyst Nitin Kumar maintains Gulfport Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPOR#NYSE">GPOR</a>) with a Neutral and raises the price target from $220 to $226.

GPOR

Mizuho Maintains Neutral on Gulfport Energy, Raises Price Target to $226

Mizuho analyst Nitin Kumar maintains Expand Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXE#NASDAQ">EXE</a>) with a Outperform and raises the price target from $136 to $141.

Mizuho Maintains Outperform on Expand Energy, Raises Price Target to $141

Mizuho analyst Nitin Kumar maintains Comstock Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRK#NYSE">CRK</a>) with a Neutral and raises the price target from $22 to $24.

Mizuho Maintains Neutral on Comstock Resources, Raises Price Target to $24

Press Releases

Apogee Therapeutics Announces First Participants Dosed in Phase 1 Clinical Trial of APG333, its Novel Half-Life Extended TSLP Antibody for the Treatment of Respiratory and Broader I&I Conditions

Apogee Therapeutics to Participate at the Guggenheim SMID Cap Biotech Conference

Apogee Therapeutics Announces First Patient Dosed in Part B of Phase 2 APEX Trial of APG777 in Patients with Moderate-to-Severe Atopic Dermatitis

Apogee Therapeutics to Participate in Upcoming March Investor Conferences

Apogee Therapeutics to Host Conference Call to Report Interim Results from the Phase 1 Healthy Volunteer Trial for APG990 and Provide Combination Strategy Update on March 3, 2025

Apogee Therapeutics Announces Positive Interim Phase 1 Results from the APG990 Healthy Volunteer Trial, Unlocking Potential Maintenance Dosing Every Three and Six Months for APG279 (APG777 + APG990)

Earnings

Apogee Therapeutics Provides Pipeline Progress and Reports Full Year 2024 Financial Results

Apogee Therapeutics to Participate at the Bank of America 2025 Health Care Conference

Health Care

Apogee Therapeutics Announces Positive Interim Results from the Phase 1b Trial of APG808, its Novel Half-life Extended IL-4Rα Antibody, in Patients with Mild-to-Moderate Asthma

Comments

Apogee Therapeutics

空売り

Apogee Therapeutics (NASDAQ:APGE) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル